Advanced Glycation End-Product Precursor Methylglyoxal May Lead to Development of Alzheimer’s Disease

References

• Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14(10):591–604. doi:10.1038/s41574-018-0048-7
   PubMed Web of Science ®Google Scholar
• Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med. 2011;1:a006189–a006189. doi:10.1101/cshperspect.a006189
   PubMed Web of Science ®Google Scholar
• Vagelatos NT, Eslick GD. Type 2 diabetes as a risk factor for Alzheimer’s disease: the confounders, interactions, and neuropathology associated with this relationship. Epidemiol Rev. 2013;35:152–160. doi:10.1093/epirev/mxs012
   Web of Science ®Google Scholar
• Li K, Li J, Zheng J, Qin S. Reactive astrocytes in neurodegenerative diseases. Aging Dis. 2019;10(3):664–675. doi:10.14336/AD.2018.0720
   PubMed Web of Science ®Google Scholar
• Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol. 2010;119(1):7–35. doi:10.1007/s00401-009-0619-8
   PubMed Web of Science ®Google Scholar
• Phillips EC, Croft CL, Kurbatskaya K, et al. Astrocytes and neuroinflammation in Alzheimer’s disease. Biochem Soc Trans. 2014;42(5):1321–1325. doi:10.1042/BST20140155
   Web of Science ®Google Scholar
• Liddelow SA, Barres BA. Reactive astrocytes: production, function, and therapeutic potential. Immunity. 2017;46(6):957–967. doi:10.1016/j.immuni.2017.06.006
   PubMed Web of Science ®Google Scholar
• Liddelow SA, Guttenplan KA, Clarke LE, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481–487. doi:10.1038/nature21029
   PubMed Web of Science ®Google Scholar
• Farina C, Aloisi F, Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol. 2007;28(3):138–145. doi:10.1016/j.it.2007.01.005
   PubMed Web of Science ®Google Scholar
• Kashon ML, Ross GW, O’Callaghan JP, et al. Associations of cortical astrogliosis with cognitive performance and dementia status. J Alzheimers Dis. 2004;6(6):595–604. doi:10.3233/JAD-2004-6604
   Web of Science ®Google Scholar
• Frost GR, Li YM. The role of astrocytes in amyloid production and Alzheimer’s disease. Open Biol. 2017;7(12):170228. doi:10.1098/rsob.170228
   PubMed Web of Science ®Google Scholar
• Wong DP, Chu JM, Hung VK, et al. Modulation of endoplasmic reticulum chaperone GRP78 by high glucose in hippocampus of streptozotocin-induced diabetic mice and C6 astrocytic cells. Neurochem Int. 2013;63(6):551–560. doi:10.1016/j.neuint.2013.09.010
   Web of Science ®Google Scholar
• Steele ML, Robinson SR. Reactive astrocytes give neurons less support: implications for Alzheimer’s disease. Neurobiol Aging. 2012;33(2):423e1–13. doi:10.1016/j.neurobiolaging.2010.09.018
   Web of Science ®Google Scholar
• Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products A review. Diabetologia. 2001;44(2):129–146. doi:10.1007/s001250051591
   PubMed Web of Science ®Google Scholar
• Srikanth V, Westcott B, Forbes J, et al. Methylglyoxal, cognitive function and cerebral atrophy in older people. J Gerontol a Biol Sci Med Sci. 2013;68(1):68–73. doi:10.1093/gerona/gls100
   Web of Science ®Google Scholar
• Kong X, Ma MZ, Huang K, et al. Increased plasma levels of the methylglyoxal in patients with newly diagnosed type 2 diabetes 2. J Diabetes. 2014;6(6):535–540. doi:10.1111/1753-0407.12160
   Web of Science ®Google Scholar
• Matafome P, Sena C, Seica R. Methylglyoxal, obesity, and diabetes. Endocrine. 2013;43(3):472–484. doi:10.1007/s12020-012-9795-8
   Web of Science ®Google Scholar
• Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, Schmidt AM. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology. 2005;15(7):16R–28R. doi:10.1093/glycob/cwi053
   PubMed Web of Science ®Google Scholar
• Kuhla B, Luth HJ, Haferburg D, Boeck K, Arendt T, Munch G. Methylglyoxal, glyoxal, and their detoxification in Alzheimer’s disease. Ann N Y Acad Sci. 2005;1043:211–216. doi:10.1196/annals.1333.026
   PubMed Web of Science ®Google Scholar
• Huang X, Wang F, Chen W, Chen Y, Wang N, von Maltzan K. Possible link between the cognitive dysfunction associated with diabetes mellitus and the neurotoxicity of methylglyoxal. Brain Res. 2012;1469:82–91. doi:10.1016/j.brainres.2012.06.011
   PubMed Web of Science ®Google Scholar
• Watanabe K, Okada K, Fukabori R, et al. Methylglyoxal (MG) and cerebro-renal interaction: does long-term orally administered MG cause cognitive impairment in normal Sprague-Dawley rats? Toxins. 2014;6(1):254–269. doi:10.3390/toxins6010254
   Web of Science ®Google Scholar
• Chun HJ, Lee Y, Kim AH, Lee J. Methylglyoxal causes cell death in neural progenitor cells and impairs adult hippocampal neurogenesis. Neurotox Res. 2016;29(3):419–431. doi:10.1007/s12640-015-9588-y
   Web of Science ®Google Scholar
• Hansen F, Pandolfo P, Galland F, et al. Methylglyoxal can mediate behavioral and neurochemical alterations in rat brain. Physiol Behav. 2016;164(Pt A):93–101. doi:10.1016/j.physbeh.2016.05.046
   PubMed Web of Science ®Google Scholar
• Szczepanik JC, de Almeida GRL, Cunha MP, Dafre AL. Repeated methylglyoxal treatment depletes dopamine in the prefrontal cortex, and causes memory impairment and depressive-like behavior in mice. Neurochem Res. 2020;45(2):354–370. doi:10.1007/s11064-019-02921-2
   Web of Science ®Google Scholar
• Chu JM, Lee DK, Wong DP, Wong GT, Yue KK. Methylglyoxal-induced neuroinflammatory response in in vitro astrocytic cultures and hippocampus of experimental animals. Metab Brain Dis. 2016;31(5):1055–1064. doi:10.1007/s11011-016-9849-3
   Web of Science ®Google Scholar
• Kim HK. Role of ERK/MAPK signalling pathway in anti-inflammatory effects of Ecklonia cava in activated human mast cell line-1 cells. Asian Pac J Trop Med. 2014;7(9):703–708.
   Web of Science ®Google Scholar
• Du Y, Du Y, Zhang Y, et al. MKP-1 reduces Abeta generation and alleviates cognitive impairments in Alzheimer’s disease models. Signal Transduct Target Ther. 2019;4:58. doi:10.1038/s41392-019-0091-4
   Web of Science ®Google Scholar
• Chen MJ, Ramesha S, Weinstock LD, et al. Microglial ERK signaling is a critical regulator of pro-inflammatory immune responses in Alzheimer’s disease. bioRxiv. 2019:798215. doi:10.1101/798215
   Google Scholar
• Li WY, Wu SL, Fcy L, Yue K. 417-P: AGE precursor methylglyoxal leads to behavioral pattern changes characteristics of Alzheimer’s Disease in mice. Diabetes. 2021;70(Supplement_1). doi:10.2337/db21-417-P
   Web of Science ®Google Scholar
• Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1(2):848–858. doi:10.1038/nprot.2006.116
   PubMed Web of Science ®Google Scholar
• Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414(December):813–820. doi:10.1038/414813a
   Web of Science ®Google Scholar
• Fleming T, Cuny J, Nawroth G, et al. Is diabetes an acquired disorder of reactive glucose metabolites and their intermediates? Diabetologia. 2012;55(4):1151–1155. doi:10.1007/s00125-012-2452-1
   Web of Science ®Google Scholar
• Sena CM, Matafome P, Crisostomo J, et al. Methylglyoxal promotes oxidative stress and endothelial dysfunction. Pharmacol Res. 2012;65(5):497–506. doi:10.1016/j.phrs.2012.03.004
   PubMed Web of Science ®Google Scholar
• Luth HJ, Ogunlade V, Kuhla B, et al. Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer’s disease brains. Cereb Cortex. 2005;15(2):211–220. doi:10.1093/cercor/bhh123
   PubMed Web of Science ®Google Scholar
• Beeri MS, Silverman J, Moshier E, et al. Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals. Alzheimers Dement. 2011;7:S144–S145. doi:10.1016/j.jalz.2011.05.388
   Google Scholar
• Kevin Flurkey JMC, Harrison DE. Mouse models in aging research. In: The Mouse in Biomedical Research. 2nd ed. Elsevier; 2007:637–672.
   Google Scholar
• Schalkwijk CG, Stehouwer CDA. Methylglyoxal, a highly reactive dicarbonyl compound, in diabetes, its vascular complications, and other age-related diseases. Physiol Rev. 2020;100(1):407–461. doi:10.1152/physrev.00001.2019
   PubMed Web of Science ®Google Scholar
• Carson MJ, Thrash JC, Walter B. The cellular response in neuroinflammation: the role of leukocytes, microglia and astrocytes in neuronal death and survival. Clin Neurosci Res. 2006;6(5):237–245. doi:10.1016/j.cnr.2006.09.004
   PubMed Web of Science ®Google Scholar
• Heneka MT, Carson MJ, Khoury JE, et al. Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 2015;14(4):388–405. doi:10.1016/s1474-4422(15)70016-5
   PubMed Web of Science ®Google Scholar
• Doyle KP, Cekanaviciute E, Mamer LE, Buckwalter MS. TGFβ signaling in the brain increases with aging and signals to astrocytes and innate immune cells in the weeks after stroke. J Neuroinflammation. 2010;7:1–13. doi:10.1186/1742-2094-7-62
   Web of Science ®Google Scholar
• Reilly JF, Maher PA, Kumari VG. Regulation of astrocyte GFAP expression by TGF-beta1 and FGF-2. Glia. 1998;22(2):202–210. doi:10.1002/(SICI)1098-1136(199802)22:2<202::AID-GLIA11>3.0.CO;2-1
   Web of Science ®Google Scholar
• Burton T, Liang B, Amara F, Amara F. Transcriptional activation and increase in expression of Alzheimer’s β-amyloid precursor protein gene is mediated by TGF-β in normal human astrocytes. Biochem Biophys Res Commun. 2002;295(3):702–712. doi:10.1016/S0006-291X(02)00724-6
   Web of Science ®Google Scholar
• Blasko I, Veerhuis R, Stampfer-Kountchev M, Saurwein-Teissl M, Eikelenboom P, Grubeck-Loebenstein B. Costimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1-40 and Abeta1-42 by human astrocytes. Neurobiol Dis. 2000;7(6Pt B):682–689. doi:10.1006/nbdi.2000.0321
   Web of Science ®Google Scholar
• Bourne KZ, Ferrari DC, Lange-Dohna C, Rossner S, Wood TG, Perez-Polo JR. Differential regulation of BACE1 promoter activity by nuclear factor-kappaB in neurons and glia upon exposure to beta-amyloid peptides. J Neurosci Res. 2007;85(6):1194–1204. doi:10.1002/jnr.21252
   Web of Science ®Google Scholar
• Cho HJ, Kim SK, Jin SM, et al. IFN-gamma-induced BACE1 expression is mediated by activation of JAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes. Glia. 2007;55(3):253–262. doi:10.1002/glia.20451
   Web of Science ®Google Scholar
• Sun L, Zhou R, Yang G, Shi Y. Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Abeta42 and Abeta40 peptides by gamma-secretase. Proc Natl Acad Sci USA. 2017;114(4):E476–E485. doi:10.1073/pnas.1618657114
   PubMed Web of Science ®Google Scholar
• Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta. 2010;1802(4):396–405. doi:10.1016/j.bbadis.2009.12.009
   PubMed Web of Science ®Google Scholar
• Subramaniam S, Unsicker K. ERK and cell death: ERK1/2 in neuronal death. FEBS J. 2010;277(1):22–29. doi:10.1111/j.1742-4658.2009.07367.x
   PubMed Web of Science ®Google Scholar
• Sun J, Nan G. The extracellular signal-regulated kinase 1/2 pathway in neurological diseases: a potential therapeutic target (Review). Int J Mol Med. 2017;39(6):1338–1346. doi:10.3892/ijmm.2017.2962
   PubMed Web of Science ®Google Scholar
• Ferrer I, Blanco R, Carmona M, et al. Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick’s disease, progressive supranuclear palsy and corticobasal degeneration. Brain Pathol. 2001;11(2):144–158. doi:10.1111/j.1750-3639.2001.tb00387.x
   PubMed Web of Science ®Google Scholar
• Tamagno E, Parola M, Bardini P, et al. Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J Neurochem. 2005;92(3):628–636. doi:10.1111/j.1471-4159.2004.02895.x
   PubMed Web of Science ®Google Scholar
• Kwak YD, Choumkina E, Sugaya K. Amyloid precursor protein is involved in staurosporine induced glial differentiation of neural progenitor cells. Biochem Biophys Res Commun. 2006;344(1):431–437. doi:10.1016/j.bbrc.2006.03.054
   Web of Science ®Google Scholar
• Tran MD. P2 receptor stimulation induces amyloid precursor protein production and secretion in rat cortical astrocytes. Neurosci Lett. 2011;492(3):155–159. doi:10.1016/j.neulet.2011.01.078
   Web of Science ®Google Scholar
• Pei JJ, Braak H, An WL, et al. Up-regulation of mitogen-activated protein kinases ERK12 and MEK12 is associated with the progression of neurofibril. Mol Brain Res. 2002;109(1–2):45–55. doi:10.1016/S0169-328X(02)00488-6
   PubMedGoogle Scholar
• Kheiri G, Dolatshahi M, Rahmani F, Rezaei N. Role of p38/MAPKs in Alzheimer’s disease: implications for amyloid beta toxicity targeted therapy. Rev Neurosci. 2018;30(1):9–30. doi:10.1515/revneuro-2018-0008
   PubMed Web of Science ®Google Scholar